Oruka Therapeutics's three largest insider shareholders as of March 23, 2026 are Healthcare Capital Partners Iii, L.P. Venrock (TenPercentOwner, 4.15Mn shares), Funds, Lp Funicular (TenPercentOwner, 4.00Mn shares), Funds, Lp Funicular (TenPercentOwner, 2.58Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Funds, Lp Funicular | 4,000,452 | 0 | 19 Dec, 2022 | |
| Fund, Lp Funicular | 2,580,452 | 0 | 25 May, 2022 | |
| Funds, Lp Funicular | 0 | 2,580,452 | 08 Jul, 2022 | |
| Henderson Group Plc Janus | 0 | 2,117,213 | 20 Aug, 2024 | |
| Lawrence Otto Klein | Chief Executive Officer | 927,309 | 0 | 17 Mar, 2026 |
| Laura Lee Sandler | Chief Operating Officer | 236,984 | 0 | 17 Mar, 2026 |
| Christopher David Ozeroff | S.V.P., General Counsel | 50,970 | 0 | 23 Nov, 2021 |
| Robert E Conway | 50,000 | 0 | 13 May, 2021 | |
| Thomas A Keuer | Chief Operating Officer | 40,730 | 0 | 09 Dec, 2022 |
| C. Jeffrey Dekker | Chief Financial Officer | 40,000 | 0 | 09 Dec, 2022 |
| Joana Goncalves | Chief Medical Officer | 33,377 | 0 | 17 Mar, 2026 |
| Paul T Quinlan | General Counsel | 31,767 | 0 | 17 Mar, 2026 |
| Arjun Agarwal | Senior Vice President, Finance | 18,863 | 0 | 17 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Lawrence Otto Klein | Common Stock | D | 1,729 | $41.30 | 927,309 | D | S |
| 16 Mar, 2026 | Laura Lee Sandler | Common Stock | D | 600 | $41.30 | 236,984 | D | S |
| 16 Mar, 2026 | Arjun Agarwal | Common Stock | D | 395 | $41.30 | 18,863 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | A | 3,500 | $6.84 | 37,518 | D | M |
| 16 Mar, 2026 | Paul T Quinlan | Common Stock | D | 733 | $41.30 | 31,767 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | A | 3,500 | $7.80 | 41,018 | D | M |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | D | 2,921 | $40.11 | 38,097 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | D | 2,902 | $41.20 | 35,195 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | D | 1,177 | $41.94 | 34,018 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Common Stock | D | 641 | $41.30 | 33,377 | D | S |
| 16 Mar, 2026 | Joana Goncalves | Employee Stock Option (right to buy) | D | 3,500 | $0.00 | 214,563 | D | M |
| 16 Mar, 2026 | Joana Goncalves | Employee Warrant (right to buy) | D | 3,500 | $0.00 | 185,992 | D | M |
| 02 Mar, 2026 | Laura Lee Sandler | Common Stock | A | 5,000 | $7.80 | 242,584 | D | M |
| 02 Mar, 2026 | Laura Lee Sandler | Common Stock | D | 2,325 | $33.28 | 240,259 | D | S |
| 02 Mar, 2026 | Laura Lee Sandler | Common Stock | D | 2,675 | $33.81 | 237,584 | D | S |
| 02 Mar, 2026 | Laura Lee Sandler | Employee Warrant (right to buy) | D | 5,000 | $0.00 | 89,996 | D | M |
| 17 Feb, 2026 | Joana Goncalves | Common Stock | A | 3,500 | $6.84 | 37,518 | D | M |
| 17 Feb, 2026 | Joana Goncalves | Common Stock | A | 3,500 | $7.80 | 41,018 | D | M |
| 17 Feb, 2026 | Joana Goncalves | Common Stock | D | 6,064 | $32.30 | 34,954 | D | S |
| 17 Feb, 2026 | Joana Goncalves | Common Stock | D | 936 | $32.78 | 34,018 | D | S |